Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Linda Nocchi is active.

Publication


Featured researches published by Linda Nocchi.


Clinical Biochemistry | 2012

Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients.

Marco Tomasetti; Sara Staffolani; Linda Nocchi; Jiri Neuzil; Elisabetta Strafella; Nicola Manzella; Laura Mariotti; Massimo Bracci; Matteo Valentino; Monica Amati; Lory Santarelli

OBJECTIVES Aim of this study was to evaluate the accuracy and precision of the detection of individual miRNA as clinical biomarkers in the serum. DESIGN AND METHODS miRNA-126 was quantified in serum using endogenous and exogenous controls for normalization and the accuracy and precision of the method evaluated. The diagnostic value of serum miRNA-126 was evaluated in malignant mesothelioma (MM) and non-small-cell lung cancer (NSCLC) patients using both relative and absolute qRT-PCR methods. RESULTS The use of endogenous invariant and exogenous synthetic controls as well sample dilution markedly improves the accuracy and precision of the assay. The inter- and intra-assay analyses revealed that relative qRT-PCR is a more reliable method. Circulating miR-126 detected in the serum by relative qRT-PCRs was found low-expressed in both malignancies, significantly differentiated MM patients from healthy controls and NSCLC from MM, but do not discriminate NSCLC patients from control subjects. Kaplan-Meier analysis revealed that low level of circulating miR-126 in MM patients was strongly associated with worse prognosis. CONCLUSIONS We propose that this approach can be adopted for accurate analysis of other suitable circulating miRNA markers of different types of cancer.


Antioxidants & Redox Signaling | 2014

MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with the Mitochondrial Function

Marco Tomasetti; Linda Nocchi; Sara Staffolani; Nicola Manzella; Monica Amati; Jacob Goodwin; Katarina Kluckova; Maria Nguyen; Elisabetta Strafella; Martina Bajzikova; Martin Peterka; Sandra Lettlova; Jaroslav Truksa; Wan Lee; Lan-Feng Dong; Lory Santarelli; Jiri Neuzil

AIMS MiR126 was found to be frequently lost in many types of cancer, including malignant mesothelioma (MM), which represents one of the most challenging neoplastic diseases. In this study, we investigated the potential tumor suppressor function of MiR126 in MM cells. The effect of MiR126 was examined in response to oxidative stress, aberrant mitochondrial function induced by inhibition of complex I, mitochondrial DNA (mtDNA) depletion, and hypoxia. RESULTS MiR126 was up-regulated by oxidative stress in nonmalignant mesothelial (Met5A) and MM (H28) cell lines. In Met5A cells, rotenone inhibited MiR126 expression, but mtDNA depletion and hypoxia up-regulated MiR126. However, these various stimuli suppressed the levels of MiR126 in H28 cells. MiR126 affected mitochondrial energy metabolism, reduced mitochondrial respiration, and promoted glycolysis in H28 cells. This metabolic shift, associated with insulin receptor substrate-1 (IRS1)-modulated ATP-citrate lyase deregulation, resulted in higher ATP and citrate production. These changes were linked to the down-regulation of IRS1 by ectopic MiR126, reducing Akt signaling and inhibiting cytosolic sequestration of Forkhead box O1 (FoxO1), which promoted the expression of genes involved in gluconeogenesis and oxidative stress defense. These metabolic changes induced hypoxia-inducible factor-1α (HIF1α) stabilization. Consequently, MiR126 suppressed the malignancy of MM cells in vitro, a notion corroborated by the failure of H28(MiR126) cells to form tumors in nude mice. INNOVATION AND CONCLUSION MiR126 affects mitochondrial energy metabolism, resulting in MM tumor suppression. Since MM is a fatal neoplastic disease with a few therapeutic options, this finding is of potential translational importance.


PLOS ONE | 2012

Alpha-Tocopheryl Succinate Inhibits Autophagic Survival of Prostate Cancer Cells Induced by Vitamin K3 and Ascorbate to Trigger Cell Death

Marco Tomasetti; Linda Nocchi; Jiri Neuzil; Jacob Goodwin; Maria Nguyen; Lan-Feng Dong; Nicola Manzella; Sara Staffolani; Claudio Milanese; Beatrice Garrone; Renata Alleva; Battista Borghi; Lory Santarelli; Roberto Guerrieri

Background The redox-silent vitamin E analog α-tocopheryl succinate (α-TOS) was found to synergistically cooperate with vitamin K3 (VK3) plus ascorbic acid (AA) in the induction of cancer cell-selective apoptosis via a caspase-independent pathway. Here we investigated the molecular mechanism(s) underlying cell death induced in prostate cancer cells by α-TOS, VK3 and AA, and the potential use of targeted drug combination in the treatment of prostate cancer. Methodology/Principal Findings The generation of ROS, cellular response to oxidative stress, and autophagy were investigated in PC3 prostate cancer cells by using drugs at sub-toxic doses. We evaluated whether PARP1-mediated apoptosis-inducing factor (AIF) release plays a role in apoptosis induced by the combination of the agents. Next, the effect of the combination of α-TOS, VK3 and AA on tumor growth was examined in nude mice. VK3 plus AA induced early ROS formation associated with induction of autophagy in response to oxidative stress, which was reduced by α-TOS, preventing the formation of autophagosomes. α-TOS induced mitochondrial destabilization leading to the release of AIF. Translocation of AIF from mitochondria to the nucleus, a result of the combinatorial treatment, was mediated by PARP1 activation. The inhibition of AIF as well as of PARP1 efficiently attenuated apoptosis triggered by the drug combination. Using a mouse model of prostate cancer, the combination of α-TOS, VK3 and AA was more efficient in tumor suppression than when the drugs were given separately, without deleterious side effects. Conclusions/Significance α-TOS, a mitochondria-targeting apoptotic agent, switches at sub-apoptotic doses from autophagy-dependent survival of cancer cells to their demise by promoting the induction of apoptosis. Given the grim prognosis for cancer patients, this finding is of potential clinical relevance.


Journal of Biological Chemistry | 2011

Thrombomodulin is silenced in malignant mesothelioma by a poly(ADP-ribose)polymerase-1-mediated epigenetic mechanism

Linda Nocchi; Marco Tomasetti; Monica Amati; Jiri Neuzil; Lory Santarelli; Franca Saccucci

Malignant mesothelioma (MM) is often complicated by thromboembolic episodes, with thrombomodulin (TM) playing a critical role in the anticoagulant process. Heterogeneous expression of TM has been observed in cancer, and low or no TM expression in cancer cells is associated with poor prognosis. In this study, we analyzed TM expression in biopsies of MM patients and compared them with normal mesothelial tissue. The role of DNA methylation-associated gene silencing in TM expression was investigated. To evaluate poly(ADP-ribose) polymerase-1 (PARP1) as responsible for gene promoter epigenetic modifications, nonmalignant mesothelial cells (Met-5A) and MM cells (H28) were silenced for PARP1 and the DNA methylation/acetylation-associated TM expression evaluated. A correlation between low TM expression and high level of TM promoter methylation was found in MM biopsies. Low expression of TM was restored in MM cells by their treatment with 5-aza-2′-deoxycytidine and, to a lesser extent, with trichostatin, whereas the epigenetic agents did not affect TM expression in Met-5A cells. Silencing of PARP1 resulted in a strong down-regulation of TM expression in Met-5A cells, while restoring TM expression in H28 cells. PARP1 silencing induced TM promoter methylation in Met-5A cells and demethylation in MM cells, and this was paralleled by corresponding changes in the DNA methyltransferase activity. We propose that methylation of the TM promoter is responsible for silencing of TM expression in MM tissue, a process that is regulated by PARP1.


British Journal of Nutrition | 2012

Effect of ascorbic acid-rich diet on in vivo-induced oxidative stress.

Renata Alleva; Ferruccio Di Donato; Elisabetta Strafella; Sara Staffolani; Linda Nocchi; Battista Borghi; Elettra Pignotti; Lory Santarelli; Marco Tomasetti

Using hyperbaric oxygen (HBO) therapy as an in vivo oxidation model, we investigated the effect of a diet enriched in ascorbic acid (AA) on HBO-induced oxidative stress. Volunteers (n 46) were allocated to the AA-rich diet group or the control group. Blood samples were collected at the basal time, after the 1-week diet before and immediately after the HBO treatment, and 1 week after the HBO treatment. AA level, total antioxidant status (TAS), hydroperoxides (HP), lymphocyte DNA oxidation and DNA repair capacity were assessed. The expression of genes involved in oxidative stress was evaluated in lymphocytes and the protein activity of the modulated genes was determined in the plasma. The AA level and the antioxidant status of plasma were increased by AA-rich food consumption. HBO exposure did not affect the AA levels or TAS, but induced HP formation in the control group. The lymphocytes isolated from dietary-supplemented subjects were resistant to ex vivo DNA oxidation, showing an increased DNA repair capacity compared with controls. A difference in gene expression pattern was observed between the groups. AA-rich foods provide dual protection against oxidative stress, enhancing plasma antioxidant levels and stimulating genes involved in cell detoxification.


Fertility and Sterility | 2010

Unexplained fetal loss: the fetal side of thrombophilia

Andrea Luigi Tranquilli; Franca Saccucci; Stefano Raffaele Giannubilo; Monia Cecati; Linda Nocchi; Sara Lorenzi; Monica Emanuelli

Carrier status of the fetus for factor V polymorphism or double homozygosity for mutant alleles of the PAI-1 4 G/4 G and MTHFR T677 T polymorphisms must be considered risk factors for intrauterine fetal death. The clinical implications of these data need to be addressed in a prospective study to confirm our preliminary data and to answer the question of whether or not double homozygous individuals should be treated with low molecular-weight heparin and/or low-dose aspirin.


Mutagenesis | 2015

Wood dust exposure induces cell transformation through EGFR-mediated OGG1 inhibition.

Sara Staffolani; Nicola Manzella; Elisabetta Strafella; Linda Nocchi; Massimo Bracci; Veronica Ciarapica; Monica Amati; Corrado Rubini; Massimo Re; Armanda Pugnaloni; Ernesto Pasquini; Paolo Tarchini; Matteo Valentino; Marco Tomasetti; Lory Santarelli

A high risk of neoplastic transformation of nasal and paranasal sinuses mucosa is related to the occupational exposure to wood dust. However, the role of occupational exposures in the aetiology of the airway cancers remains largely unknown. Here, an in vitro model was performed to investigate the carcinogenic effect of wood dusts. Human bronchial epithelial cells were incubated with hard and soft wood dusts and the DNA damage and response to DNA damage evaluated. Wood dust exposure induced accumulation of oxidised DNA bases, which was associated with a delay in DNA repair activity. By exposing cells to wood dust at a prolonged time, wood dust-initiated cells were obtained. Initiated-cells were able to form colonies in soft agar, and to induce blood vessel formation. These cells showed extensive autophagy, reduced DNA repair, which was associated with reduced OGG1 expression and oxidised DNA base accumulation. These events were found related to the activation of EGFR/AKT/mTOR pathway, through phosphorylation and subsequent inactivation of tuberin. The persistence in the tissue of wood dusts, their repetitious binding with EGFR may continually trigger the activation switch, leading to chronic down-regulation of genes involved in DNA repair, leading to cell transformation and proliferation.


Journal of Biological Regulators and Homeostatic Agents | 2013

Influence of night-shift and napping at work on urinary melatonin, 17-β-estradiol and clock gene expression in pre-menopausal nurses.

Massimo Bracci; Alfredo Copertaro; Nicola Manzella; Sara Staffolani; Elisabetta Strafella; Linda Nocchi; Mariella Barbaresi; Benedetta Copertaro; Rapisarda; Matteo Valentino; Lory Santarelli


Lung Cancer | 2015

Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma

Lory Santarelli; Sara Staffolani; Elisabetta Strafella; Linda Nocchi; Nicola Manzella; Paola Grossi; Massimo Bracci; Elettra Pignotti; Renata Alleva; Battista Borghi; Cecilia Pompili; Armando Sabbatini; Corrado Rubini; Lina Zuccatosta; Elisabetta Bichisecchi; Matteo Valentino; Keith Horwood; Manola Comar; Massimo Bovenzi; Lan-Feng Dong; Jiri Neuzil; Monica Amati; Marco Tomasetti


Mutagenesis | 2011

Asbestos exposure affects poly(ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis

Marco Tomasetti; Monica Amati; Linda Nocchi; Franca Saccucci; Elisabetta Strafella; Sara Staffolani; Lucia Miria Tarquini; Damiano Carbonari; Renata Alleva; Battista Borghi; Jiri Neuzil; Massimo Bracci; Lory Santarelli

Collaboration


Dive into the Linda Nocchi's collaboration.

Top Co-Authors

Avatar

Lory Santarelli

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar

Marco Tomasetti

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar

Elisabetta Strafella

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar

Sara Staffolani

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar

Monica Amati

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Massimo Bracci

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar

Franca Saccucci

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar

Matteo Valentino

Marche Polytechnic University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge